STAA
Price
$27.15
Change
-$0.01 (-0.04%)
Updated
Sep 18, 04:59 PM (EDT)
Capitalization
1.34B
40 days until earnings call
XRAY
Price
$13.41
Change
-$0.02 (-0.15%)
Updated
Sep 18, 04:59 PM (EDT)
Capitalization
2.68B
41 days until earnings call
Interact to see
Advertisement

STAA vs XRAY

Header iconSTAA vs XRAY Comparison
Open Charts STAA vs XRAYBanner chart's image
STAAR Surgical
Price$27.15
Change-$0.01 (-0.04%)
Volume$43.42K
Capitalization1.34B
DENTSPLY SIRONA
Price$13.41
Change-$0.02 (-0.15%)
Volume$37.64K
Capitalization2.68B
STAA vs XRAY Comparison Chart in %
Loading...
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STAA vs. XRAY commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STAA is a Hold and XRAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 19, 2025
Stock price -- (STAA: $27.17 vs. XRAY: $13.43)
Brand notoriety: STAA and XRAY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: STAA: 53% vs. XRAY: 82%
Market capitalization -- STAA: $1.35B vs. XRAY: $2.68B
STAA [@Pharmaceuticals: Other] is valued at $1.35B. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.68B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.76B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STAA’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • STAA’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, XRAY is a better buy in the long-term than STAA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STAA’s TA Score shows that 3 TA indicator(s) are bullish while XRAY’s TA Score has 4 bullish TA indicator(s).

  • STAA’s TA Score: 3 bullish, 5 bearish.
  • XRAY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than STAA.

Price Growth

STAA (@Pharmaceuticals: Other) experienced а -1.79% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -1.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.10%. For the same industry, the average monthly price growth was +2.60%, and the average quarterly price growth was +6.69%.

Reported Earning Dates

STAA is expected to report earnings on Oct 29, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($2.68B) has a higher market cap than STAA($1.34B). STAA YTD gains are higher at: 11.816 vs. XRAY (-27.895). STAA has higher annual earnings (EBITDA): -73.24M vs. XRAY (-689M). XRAY has more cash in the bank: 359M vs. STAA (190M). STAA has less debt than XRAY: STAA (40.5M) vs XRAY (2.49B). XRAY has higher revenues than STAA: XRAY (3.67B) vs STAA (224M).
STAAXRAYSTAA / XRAY
Capitalization1.34B2.68B50%
EBITDA-73.24M-689M11%
Gain YTD11.816-27.895-42%
P/E Ratio49.73N/A-
Revenue224M3.67B6%
Total Cash190M359M53%
Total Debt40.5M2.49B2%
FUNDAMENTALS RATINGS
STAA vs XRAY: Fundamental Ratings
STAA
XRAY
OUTLOOK RATING
1..100
5362
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
4264
P/E GROWTH RATING
1..100
8785
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for STAA (86). This means that XRAY’s stock grew significantly faster than STAA’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as STAA (100). This means that XRAY’s stock grew similarly to STAA’s over the last 12 months.

STAA's SMR Rating (96) in the Medical Specialties industry is in the same range as XRAY (97). This means that STAA’s stock grew similarly to XRAY’s over the last 12 months.

STAA's Price Growth Rating (42) in the Medical Specialties industry is in the same range as XRAY (64). This means that STAA’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's P/E Growth Rating (85) in the Medical Specialties industry is in the same range as STAA (87). This means that XRAY’s stock grew similarly to STAA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STAAXRAY
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 4 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 14 days ago
74%
Bullish Trend 3 days ago
58%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 9 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTNX18.330.18
+0.99%
Artisan Select Equity Investor
RIIEX44.700.01
+0.02%
American Funds Intl Gr and Inc R2E
CAAIX43.07N/A
N/A
Ariel Appreciation Institutional
JERTX12.43N/A
N/A
Janus Henderson Global Real Estate T
TRRPX18.09N/A
N/A
Nuveen Real Estate Sec Sel Premier

STAA and

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with XRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
N/A
XRAY - STAA
53%
Loosely correlated
-0.15%
WST - STAA
44%
Loosely correlated
-0.65%
OFIX - STAA
38%
Loosely correlated
+3.61%
CSTL - STAA
38%
Loosely correlated
+7.56%
IQV - STAA
37%
Loosely correlated
+1.88%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-0.15%
NVST - XRAY
54%
Loosely correlated
+0.24%
QDEL - XRAY
50%
Loosely correlated
+3.52%
KIDS - XRAY
48%
Loosely correlated
+4.43%
STE - XRAY
46%
Loosely correlated
+0.69%
AZTA - XRAY
46%
Loosely correlated
+1.92%
More